2022 PCRI MOYAD + SCHOLZ MID-YEAR UPDATE
WATCH THE REPLAYS
REPLAY! Click The Video Above To Watch Day 1
REPLAY! Click The Video Above To Watch Day 2
The 2022 Moyad + Scholz Mid-Year Update is a two-day online educational event for prostate cancer patients and caregivers. Join other patients and caregivers who will be attending from across the US and internationally. This year will be the 8th annual mid-year conference, and we are proud to welcome a distinguished faculty. We will be covering topics including advanced cancer, active surveillance, radiation treatment, imaging, erectile dysfunction, and incontinence. The conference is moderated by Mark Moyad, MD, who moderates the Q+A sessions following each lecture, and ensures that anything unclear becomes understood. At the end of the conference, Drs. Mark Scholz and Mark Moyad host an extended Q+A session about prostate cancer, where patients can get their questions answered. Overall, the Moyad + Scholz Mid-Year Update is a unique full-featured educational experience for patients to access valuable resources and information ultimately find hope and empowerment. Donate to PCRI!
*Please note, this broadcast will remain posted here indefinitely and on our YouTube channel for viewing after the broadcast is over.
2022 SPEAKERS + TOPICS
Nicholas J. Vogelzang, MD
Chairman of Medical Oncology, Comprehensive Cancer Center. Vice Chair, GU Committee SWOG. Clinical Professor of Medicine at University of Nevada
Advanced Prostate cancer UPDATE (INCLUDING THE LATEST FDA APPROVED THERAPIES)
Matthew Cooperberg, MD
Professor of Urology; Epidemiology & Biostatistics, Helen Diller Family Chair in Urology, UCSF
PSA Screening UPDATE & ACTIVE SURVEILLANCE FOR PROSTATE CANCER
Eugene Kwon, MD
Professor of Urology, Professor of Immunology
Mayo Clinic
THE LATEST ON PROSTATE IMAGING, OTHER TREATMENTS, & PATIENT EMPOWERMENT
Jeffrey Brady, MD
Urologist,
AdventHealth Medical Group
INCONTINENCE TREATMENT OPTIONS | surgical & NON SURGICAL
Amar Kishan, MD
Associate Professor, Chief of the Genitourinary Oncology Service, Department of Radiation Oncology, UCLA
Radiation (INCLUDING THE LATEST ON SBRT & MANAGING SIDE EFFECTS
Mark Scholz, MD
Medical Director, Prostate Oncology Specialists &
Executive Director, PCRI
8TH Annual Moyad and Scholz Free for All! Any question on any aspect of prostate cancer!
Mark Moyad, MD, MPH
Jenkins/Pokempner Director of Preventive and Alternative Medicine Education, University of Michigan, Department of Urology
8TH Annual Moyad and Scholz Free for All! Any question on any aspect of prostate cancer!!
AGENDA
Saturday, MARCH 26, 2022 (all times in PAcific Daylight Time)
8:30am - 9:00am PDT | Opening Remarks with Mark Moyad, MD
9:00am - 10:30am PDT | Screening & Active Surveillance | Matthew Cooperberg, MD
10:30am - 1:00pm PDT | Incontinence & ED Medical/Surgical Treatments | Jeffrey Brady, MD
1:00pm - 1:30pm PDT | Sponsored Presentation
1:30pm - 4:00pm PDT | Prostate Treatments & Imaging | Eugene Kwon, MD
4:00pm PDT | Closing Remarks
SUNDAY, MARCH 27, 2022
8:30am - 10:30am PDT | Radiation Therapy & Side Effects | Amar Kishan, MD
10:30am - 1:00pm PDT | Advanced Treatment & Side Effects | Nicholas J. Vogelzang, MD
1:00pm - 3:30pm PDT | 2022 Update - Bring it on! 8th Annual Moyad and Scholz Free for All! Any Question on Any Aspect of Prostate Cancer! | Mark Moyad, MD & Mark Scholz, MD
3:30pm | Closing Remarks
*Agenda is subject to change
Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs.
This information has been reviewed according to the US law and is consistent with US Prescribing Information and is intended for US audience only. Prescribing Information may vary depending on local approval in each country.
Product:
LEARN MORE ABOUT NUBEQA (DAROLUTAMIDE)
Prescribing Information:
http://labeling.bayerhealthcare.com/html/products/pi/Nubeqa_PI.pdf
Other educational resources:
Nubeqa Patient Information
http://labeling.bayerhealthcare.com/html/products/pi/Nubeqa_PatientInfo.pdf
Financial Resources:
Access Support Resources
https://www.nubeqa-us.com/support
LEARN MORE ABOUT XOFIGO (radium Ra 223 dichloride)
Prescribing Information:
https://www.xofigo-us.com/sites/g/files/vrxlpx3306/files/2020-09/Xofigo_PI.pdf
Other educational resources:
How Xofigo Works
https://www.xofigo-us.com/patient/how-xofigo-works
Financial Resources:
Access Support Resources
https://www.xofigo-us.com/patient/xofigo-support
Product:
Erleada:
Prescribing Information:
http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/ERLEADA-pi.pdf
Other educational resources:
My Prostate Cancer Roadmap:
https://www.myprostatecancerroadmap.com
Financial Resources:
Janssen CarePath:
https://www.erleada.com/janssen-carepath/cost-support
Know Your State Access & Affordability Tool: https://www.janssencarepath.com/sites/www.janssencarepath.com/files/know-your-state.pdf
EDUCATIONAL RESOURCES
Living With Cancer Website:
https://www.thisislivingwithcancer.com/living-with-app
Living With Cancer iTunes App:
https://apps.apple.com/us/app/id1223073769
Know Your Prostate Plan – Patient Videos
PROVENGE
PRESCRIBING INFORMATION:
https://www.provengehcp.com/Portals/5/Provenge-PI.pdf
OTHER RESOURCES:
Provenge Support Information
https://www.provenge.com/Support
Your Provenge Experience:
AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Product Website
Learn about theragnostics:
About Tolmar:
Tolmar is committed to the development, approval, and commercialization of specialty pharmaceutical products dedicated to advancing patient care in urology. We are focused on the needs of today, with a vision of tomorrow that drives our dedication to the urology community and the patients it serves.
To learn more, visit www.tolmar.com
To learn more about Eligard, visit https://eligard.com/
PAN FOUNDATION
We help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.
RESOURCES:
The PAN Foundation: https://www.panfoundation.org/
Our disease funds: https://www.panfoundation.org/find-disease-fund/
Find patient assistance in minutes! Sign up for FundFinder: https://fundfinder.panfoundation.org/
Become an advocate: https://www.panfoundation.org/become-an-advocate/
LEARN ABOUT ALL THAT PCRI HAS TO OFFER
The PCRI provides resources for prostate cancer patients and caregivers looking to gain understanding, insight, and hope. Get honest answers from science based data.
Hello Researcher! We are the Prostate Cancer Research Institute (PCRI), a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for you. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call us at 1 (800) 641-7274 with any question that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
